Johannes Hamann

Summary

Country: Germany

Publications

  1. ncbi request reprint Antipsychotic prescribing patterns in Germany: a retrospective analysis using a large outpatient prescription database
    Johannes Hamann
    Center for Disease Management, Klinik und Poliklinik fur Psychiatrie und Psychotherapie der Technischen Universitat Munchen, Munchen, Germany
    Int Clin Psychopharmacol 18:237-42. 2003
  2. ncbi request reprint Medical decision making in the mental health field
    Johannes Hamann
    Psychiatr Serv 56:221. 2005
  3. ncbi request reprint How do psychiatrists choose among different antipsychotics?
    Johannes Hamann
    Department for Psychiatry and Psychotherapy, Technische Universitat, Möhlstrasse 26, 81675 Munich, Germany
    Eur J Clin Pharmacol 61:851-4. 2005
  4. ncbi request reprint Physicians' and patients' involvement in relapse prevention with antipsychotics in schizophrenia
    Johannes Hamann
    Psychiatry Department, Technische Universitat Munchen, Germany
    Psychiatr Serv 56:1448-50. 2005
  5. ncbi request reprint Attitudes of psychiatrists toward antipsychotic depot medication
    Stephan Heres
    Klinik und Poliklinik fuer Psychiatrie und Psychotherapie der Technischen, Universitaet Muenchen am Klinikum rechts der, Muenchen, Germany
    J Clin Psychiatry 67:1948-53. 2006
  6. ncbi request reprint Medical decision making in antipsychotic drug choice for schizophrenia
    Johannes Hamann
    Psychiatric Department, Technical University of Munich, Möhlstrasse 26, 81675 Munich, Germany
    Am J Psychiatry 161:1301-4. 2004
  7. doi request reprint Psychiatrists' decision making between branded and generic drugs
    Johannes Hamann
    Psychiatric Department, Technical University Munich, Munich, Germany
    Eur Neuropsychopharmacol 23:686-90. 2013
  8. ncbi request reprint Do patients with schizophrenia wish to be involved in decisions about their medical treatment?
    Johannes Hamann
    Klinik und Poliklinik fur Psychiatrie und Psychotherapie, Möhlstrasse 26, 81675 Munchen, Germany
    Am J Psychiatry 162:2382-4. 2005
  9. doi request reprint Psychiatrists' use of shared decision making in the treatment of schizophrenia: patient characteristics and decision topics
    Johannes Hamann
    Department of Psychiatry, Technische Universitat Munchen, Möhlstrasse 26, 81675 Munchen, Germany
    Psychiatr Serv 60:1107-12. 2009
  10. doi request reprint "How to speak to your psychiatrist": shared decision-making training for inpatients with schizophrenia
    Johannes Hamann
    Psychiatric Department, Technische Universitat Munchen, Munich, Germany
    Psychiatr Serv 62:1218-21. 2011

Detail Information

Publications24

  1. ncbi request reprint Antipsychotic prescribing patterns in Germany: a retrospective analysis using a large outpatient prescription database
    Johannes Hamann
    Center for Disease Management, Klinik und Poliklinik fur Psychiatrie und Psychotherapie der Technischen Universitat Munchen, Munchen, Germany
    Int Clin Psychopharmacol 18:237-42. 2003
    ..It is important to raise awareness among non-specialists about the indications, efficacy and side-effects of the antipsychotics because these physicians account for the majority of antipsychotic prescriptions...
  2. ncbi request reprint Medical decision making in the mental health field
    Johannes Hamann
    Psychiatr Serv 56:221. 2005
  3. ncbi request reprint How do psychiatrists choose among different antipsychotics?
    Johannes Hamann
    Department for Psychiatry and Psychotherapy, Technische Universitat, Möhlstrasse 26, 81675 Munich, Germany
    Eur J Clin Pharmacol 61:851-4. 2005
    ..We attempted to determine the decision rules psychiatrists use in the choice of antipsychotic drugs for inpatients with schizophrenia...
  4. ncbi request reprint Physicians' and patients' involvement in relapse prevention with antipsychotics in schizophrenia
    Johannes Hamann
    Psychiatry Department, Technische Universitat Munchen, Germany
    Psychiatr Serv 56:1448-50. 2005
    ..Accordingly, patients' knowledge of the optimal duration of maintenance therapy was poor...
  5. ncbi request reprint Attitudes of psychiatrists toward antipsychotic depot medication
    Stephan Heres
    Klinik und Poliklinik fuer Psychiatrie und Psychotherapie der Technischen, Universitaet Muenchen am Klinikum rechts der, Muenchen, Germany
    J Clin Psychiatry 67:1948-53. 2006
    ..Nevertheless, long-acting injectable formulations are seldom prescribed in the treatment of schizophrenia...
  6. ncbi request reprint Medical decision making in antipsychotic drug choice for schizophrenia
    Johannes Hamann
    Psychiatric Department, Technical University of Munich, Möhlstrasse 26, 81675 Munich, Germany
    Am J Psychiatry 161:1301-4. 2004
    ..The influence of patient and physician variables on antipsychotic drug choice for patients with schizophrenia was assessed...
  7. doi request reprint Psychiatrists' decision making between branded and generic drugs
    Johannes Hamann
    Psychiatric Department, Technical University Munich, Munich, Germany
    Eur Neuropsychopharmacol 23:686-90. 2013
    ....
  8. ncbi request reprint Do patients with schizophrenia wish to be involved in decisions about their medical treatment?
    Johannes Hamann
    Klinik und Poliklinik fur Psychiatrie und Psychotherapie, Möhlstrasse 26, 81675 Munchen, Germany
    Am J Psychiatry 162:2382-4. 2005
    ..Little is known about the desire of patients with schizophrenia to be involved in medical decisions affecting their treatment...
  9. doi request reprint Psychiatrists' use of shared decision making in the treatment of schizophrenia: patient characteristics and decision topics
    Johannes Hamann
    Department of Psychiatry, Technische Universitat Munchen, Möhlstrasse 26, 81675 Munchen, Germany
    Psychiatr Serv 60:1107-12. 2009
    ..This study explored psychiatrists' views of shared decision making in schizophrenia treatment...
  10. doi request reprint "How to speak to your psychiatrist": shared decision-making training for inpatients with schizophrenia
    Johannes Hamann
    Psychiatric Department, Technische Universitat Munchen, Munich, Germany
    Psychiatr Serv 62:1218-21. 2011
    ..This study evaluated a new intervention...
  11. ncbi request reprint How long do psychiatrists wait for response before they switch to another antipsychotic?
    Johannes Hamann
    Psychiatric Department, Technische Universitat Munchen, Möhlstraße 26, Munchen, Germany
    Psychopharmacol Bull 40:149-54. 2007
    ..In practice, this might result in different lengths of drug trials for individual patients depending on the admitting hospital. Evidence based guidance for psychiatrists is needed to avoid too early switches or too long drug trials...
  12. ncbi request reprint Amisulpride is an "atypical" antipsychotic associated with low weight gain
    Stefan Leucht
    Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar der Technischen Universitat Munchen, Ismaningerstrasse 22, 81675 Munich, Germany
    Psychopharmacology (Berl) 173:112-5. 2004
    ..While most "atypicals" have a high affinity for both dopamine and serotonin receptors, amisulpride has only dopamine receptor action...
  13. ncbi request reprint Psychiatric decision making in the adoption of a new antipsychotic in Germany
    Johannes Hamann
    Technische Universitat Munchen, Möhlstrasse 26, Muenchen, Germany 81675
    Psychiatr Serv 57:700-3. 2006
    ..Studies in somatic medicine have demonstrated delays in the implementation of new drugs, but data on psychiatric drugs are scarce. This study examined psychiatrists' adoption of a new antipsychotic...
  14. ncbi request reprint Medication adherence studies in schizophrenia
    Johannes Hamann
    Am J Psychiatry 161:582; author reply 582-3. 2004
  15. doi request reprint Patients' and psychiatrists' perceptions of clinical decisions during schizophrenia treatment
    Johannes Hamann
    Klinik und Poliklinik für Psychiatrie und Psychotherapie der TU München, Munchen, Germany
    J Nerv Ment Dis 196:329-32. 2008
    ..This is especially true of those being treated involuntarily...
  16. doi request reprint [Patient participation in german psychiatry - a critical review]
    Tatjana Reichhart
    Centrum für Disease Management, Klinik und Poliklinik fur Psychiatrie und Psychotherapie der Technischen Universitat Munchen
    Psychiatr Prax 35:111-21. 2008
    ..A comprehensive review of the present state and new approaches of patient participation in German psychiatry was conducted...
  17. pmc Methodological issues in current antipsychotic drug trials
    Stefan Leucht
    Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar der Technischen Universitat Munchen, Ismaningerstr 22, 81675 Munchen, Germany
    Schizophr Bull 34:275-85. 2008
    ..The authors present practical examples to highlight the current problems and propose a concrete series of suggestions on how to further optimize antipsychotic drug trials in the future...
  18. ncbi request reprint Clinical implications of Brief Psychiatric Rating Scale scores
    Stefan Leucht
    Klinik fürr Psychiatrie und Psychotherapie derTechnischen Universität München, Klinikum rechts der Isar, Ismaningerstrasse 22, 81675 Munchen, Germany
    Br J Psychiatry 187:366-71. 2005
    ..Despite the widespread use of the Brief Psychiatric Rating Scale (BPRS), the clinical meaning of its total score and cut-off values used to define treatment response are unclear...
  19. ncbi request reprint Shared decision making and long-term outcome in schizophrenia treatment
    Johannes Hamann
    Department of Psychiatry, Technische Universitat, Munich, Germany
    J Clin Psychiatry 68:992-7. 2007
    ..The aim of the present analysis was to study whether shared decision making (SDM) in antipsychotic drug choice would influence long-term outcome...
  20. ncbi request reprint Pretrial medication bias in randomized antipsychotic drug trials
    Stefan Leucht
    Am J Psychiatry 164:1266; author reply 1266-7. 2007
  21. ncbi request reprint Early-onset hypothesis of antipsychotic drug action: a hypothesis tested, confirmed and extended
    Stefan Leucht
    Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar der Technischen Universitat Munchen, Munich, Germany
    Biol Psychiatry 57:1543-9. 2005
    ....
  22. ncbi request reprint Linking the PANSS, BPRS, and CGI: clinical implications
    Stefan Leucht
    Klinik für Psychiatrie und Psychotherapie der TU München, Klinikum rechts der Isar, Munich, Munchen, Germany
    Neuropsychopharmacology 31:2318-25. 2006
    ..Clinicians seem to base CGI ratings on relative change rather than on absolute change of symptoms...
  23. ncbi request reprint What does the PANSS mean?
    Stefan Leucht
    Klinik für Psychiatrie und Psychotherapie der TU München Klinikum rechts der Isar, Ismaningerstr 22, 81675 Munchen, Germany
    Schizophr Res 79:231-8. 2005
    ..g. at least 20% or 50% reduction of the baseline score) are as yet unclear. We therefore compared the PANSS with simultaneous ratings of Clinical Global Impressions (CGI)...
  24. ncbi request reprint New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis
    Stefan Leucht
    Klinik und Poliklinik fur Psychiatrie und Psychotherapie der Technischen Universitat Munchen, Klinikum rechts der Isar, Munchen, Germany
    Lancet 361:1581-9. 2003
    ..We aimed to establish whether the new drugs induce fewer EPS than low-potency conventional antipsychotics...